Literature DB >> 7836442

Interaction with TrkA immobilizes gp75 in the high affinity nerve growth factor receptor complex.

D E Wolf1, C A McKinnon, M C Daou, R M Stephens, D R Kaplan, A H Ross.   

Abstract

It has been proposed that the high affinity nerve growth factor (NGF) receptor required for NGF response is a complex of two receptor proteins, gp75 and the tyrosine kinase TrkA, but direct biochemical or biophysical evidence has been lacking. We have previously shown using fluorescence recovery after photobleaching that gp75 is highly mobile on NGF-nonresponsive cells, but relatively immobile on NGF-responsive cells. In this report, we show that a physical interaction with TrkA causes gp75 immobilization. We found that gp75 is relatively mobile on TrkA negative nnr5 cells, a PC12 variant which is nonresponsive to NGF. In contrast, on T14 nnr5 cells (which bear a TrkA expression vector) gp75 is relatively immobile. Similarly, using baculoviruses to express gp75 and TrkA on Sf9 insect cells, we found that TrkA immobilizes gp75 molecules. The related receptor, TrkB, caused a more modest immobilization of gp75. Immobilization was found to require intact TrkA kinase and gp75 cytoplasmic domains, paralleling the requirements of high affinity binding of NGF. Analysis of gp75 diffusion coefficients indicates that mutated gp75 and TrkA molecules may form a complex, even in the absence of the ability to bind NGF with high affinity.

Mesh:

Substances:

Year:  1995        PMID: 7836442     DOI: 10.1074/jbc.270.5.2133

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  p75 is important for axon growth and schwann cell migration during development.

Authors:  C A Bentley; K F Lee
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  PLAIDD, a type II death domain protein that interacts with p75 neurotrophin receptor.

Authors:  Harald Frankowski; Susana Castro-Obregon; Gabriel del Rio; Rammohan V Rao; Dale E Bredesen
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

3.  Proteolytic processing of the p75 neurotrophin receptor and two homologs generates C-terminal fragments with signaling capability.

Authors:  Kevin C Kanning; Mark Hudson; Paul S Amieux; Jesse C Wiley; Mark Bothwell; Leslayann C Schecterson
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

4.  Functional interaction between p75NTR and TrkA: the endocytic trafficking of p75NTR is driven by TrkA and regulates TrkA-mediated signalling.

Authors:  Lorena Perrone; Simona Paladino; Marialuisa Mazzone; Lucio Nitsch; Massimo Gulisano; Chiara Zurzolo
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

5.  The neurotrophin receptor p75 binds neurotrophin-3 on sympathetic neurons with high affinity and specificity.

Authors:  G Dechant; P Tsoulfas; L F Parada; Y A Barde
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

6.  The trkA receptor mediates growth cone turning toward a localized source of nerve growth factor.

Authors:  G Gallo; F B Lefcort; P C Letourneau
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

7.  Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor.

Authors:  M H Cortazzo; E S Kassis; K A Sproul; N F Schor
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

8.  Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival.

Authors:  S O Yoon; P Casaccia-Bonnefil; B Carter; M V Chao
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

9.  Optimal nerve growth factor trophic signals mediated by synergy of TrkA and p75 receptor-specific ligands.

Authors:  S Maliartchouk; H U Saragovi
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

10.  Comparison of nerve growth factor receptor binding models using heterodimeric muteins.

Authors:  Hrishikesh M Mehta; Sang B Woo; Kenneth E Neet
Journal:  J Neurosci Res       Date:  2012-08-18       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.